A new publication involving protirelin was released on August 18, 2026. The study, titled "Horses with pituitary pars intermedia dysfunction have an altered fecal short-chain fatty acid profile," appeared in the American Journal of Veterinary Research.
This is a publication event, meaning the study has been published in the listed journal on the stated date. No findings or results beyond the title are provided in this event data. The publication pertains to horses with pituitary pars intermedia dysfunction, a condition sometimes assessed using protirelin.
Readers interested in the full study details, including methodology and any reported outcomes, are encouraged to consult the original source directly via PubMed.
For general background on protirelin, including its approved regulatory status and typical uses, readers can refer to the compound overview.